Hemoglobinopathy screening in primary care in the Netherlands: exploring the problems and needs of patients and general practitioners
- PMID: 35945245
- PMCID: PMC10133269
- DOI: 10.1038/s41431-022-01156-0
Hemoglobinopathy screening in primary care in the Netherlands: exploring the problems and needs of patients and general practitioners
Abstract
The prevalence of hemoglobinopathies in The Netherlands is increasing due to migration. Hemoglobinopathies are severe hereditary diseases. An informed reproductive choice by at-risk couples, such as pre-implantation diagnosis or termination of affected pregnancies, can be made if carriers are detected prior to conception. Using a qualitative design, the needs and wishes of patients, carriers and general practitioners were evaluated regarding carrier detection of hemoglobinopathies in primary care practice. 30 semi-structured interviews were established with 10 general practitioners, 10 patients and 10 carriers. The interviews were audio-recorded, transcribed verbatim and analysed using content analysis to identify recurring themes. Three themes were generated regarding carrier detection of hemoglobinopathies: (1) a need for more information about hemoglobinopathy, (2) a need for indications when to refer for analysis (carrier diagnostics) and (3) insight concerning organization and roles in care for hemoglobinopathy carriers and patients. These themes reflected a need to increase awareness of hemoglobinopathy, improve competences among general practitioners through better education and improvement of communication with patients and their unidentified family members. This study shows the scope of the problem and the critical need for action to improve informed reproductive decision making for the at-risk population.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Hemoglobinopathy prevention in primary care: a reflection of underdetection and difficulties with accessibility of medical care, a quantitative study.Eur J Hum Genet. 2022 Jul;30(7):790-794. doi: 10.1038/s41431-022-01051-8. Epub 2022 Feb 25. Eur J Hum Genet. 2022. PMID: 35217803 Free PMC article.
-
Carrier screening for thalassemia and hemoglobinopathies in Canada.J Obstet Gynaecol Can. 2008 Oct;30(10):950-959. doi: 10.1016/S1701-2163(16)32975-9. J Obstet Gynaecol Can. 2008. PMID: 19038079 Review. English, French.
-
Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study.J Genet Couns. 2018 Jun;27(3):635-646. doi: 10.1007/s10897-017-0159-7. Epub 2017 Oct 5. J Genet Couns. 2018. PMID: 28980104 Free PMC article.
-
Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.BMC Public Health. 2009 Sep 15;9:338. doi: 10.1186/1471-2458-9-338. BMC Public Health. 2009. PMID: 19754950 Free PMC article.
-
Genetic epidemiology and preventive healthcare in multiethnic societies: the hemoglobinopathies.Int J Environ Res Public Health. 2014 Jun 11;11(6):6136-46. doi: 10.3390/ijerph110606136. Int J Environ Res Public Health. 2014. PMID: 24921462 Free PMC article. Review.
Cited by
-
Building capacity for genomics in primary care: a scoping review of practitioner attitudes, education needs, and enablers.Front Med (Lausanne). 2025 Apr 30;12:1577958. doi: 10.3389/fmed.2025.1577958. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40370713 Free PMC article.
References
-
- Kerkhoffs JLH PG, Wijermans PW. Sikkelcelziekte en thalassemie in Den Haag: een perspectief voor een Haags Hemoglobinopathie Centrum? Epidemiologisch bulletin 2007, jaargang 42, nummer 1.
-
- RIVM. Heel prick screening test https://www.pns.nl/prenatal-and-newborn-screening/heel-prick2022.
MeSH terms
LinkOut - more resources
Full Text Sources